Hologic, Inc.

HOLX

$79.77

+11.4% last 12 months

Jim Simons Holding value: $202 Million Ray Dalio Holding value: $35.6 Million Ken Griffin Holding value: $20.6 Million Joel Greenblatt Holding value: $2.27 Million Ken Fisher Holding value: $1.04 Million Steven Cohen Holding value: $0 Jeremy Grantham Holding value: $0 Julian Robertson Holding value: $0 Mario Gabelli Holding value: $0 Stanley Druckenmiller Holding value: $0 George Soros Holding value: $0 Carl Icahn Holding value: $0 Prem Watsa Holding value: $0

Market Cap

$19.8 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$59.78 - $86.65

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

20.03x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $19.8 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. $20.2 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $0.00 (0.0%)
1 Year Return Profit or loss of share price change plus dividend yield. +11.4%
52-Week High Highest share price in the last 52 weeks. $86.65
52-Week Low Lowest share price in the last 52 weeks. $59.78
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.0
Outstanding Shares The number of shares the company has issued and are held by stockholders. 247 Million
Avg 30 Day Volume The number of shares traded in the last 30 days. 1.43 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 20.03
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -32.07
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $3.93
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 4.43
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 3.99
Enterprise Value to Revenue Enterprise value divided by revenue 4.53
Enterprise Value to EBIT Enterprise Value divided by EBIT 15.88
Total Debt to Enterprise Value Total debt divided by enterprise value 0.14
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.56

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. $4.47 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. $2.92 Billion
EBIT Earnings before tax and interest payments. $1.27 Billion
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. $990 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 22.17%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -62.5%
Return on Equity Equity divided by market cap. 19.44%
Return on Assets Indicates a company's profitability in relation to its total assets. 10.66%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 15.29%

Insider trades

No purchases

9,710.0 shares sold (2 transactions)

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q2 2022 Q3 2022 Q4 2022 Q1 2023

About Hologic, Inc.

CEO: Stephen MacMillan

Employees: 6,478

Industry: Irradiation Apparatus Manufacturing

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

Similar stocks

Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Becton, Dickinson And Co.
Becton, Dickinson And Co.
Boston Scientific Corp.
Boston Scientific Corp.
Abbott Laboratories
Abbott Laboratories
General Electric Co.
General Electric Co.
Koninklijke Philips N.V. - ADR
Koninklijke Philips N.V. - ADR
Quest Diagnostics, Inc.
Quest Diagnostics, Inc.
Johnson & Johnson
Johnson & Johnson

News

Hologic Stands Up To ''Business As Usual'' To Prioritize Women''s Health

Hologic Stands Up To ''Business As Usual'' To Prioritize Women''s Health

CEO Steve MacMillan leads charge for a global ''what gets measured gets results'' tool.

IBTimes IBTimes, 6 days ago
Fungal Testing Kits Market May Hit US$ 4504 million by 2033, at a 10.1% CAGR | Future Market Insights, Inc.

Fungal Testing Kits Market May Hit US$ 4504 million by 2033, at a 10.1% CAGR | Future Market Insights, Inc.

NEWARK, DE / ACCESSWIRE / March 6, 2023 / With a projected Fungus Testing Kits Market size of over US$ 1.72 billion as of 2023, the global fungus testing equ...

Accesswire Accesswire, 16 days ago
Hologic $HOLX Investment Analysis and Advice

Hologic $HOLX Investment Analysis and Advice

Timing Trades in Hologic HOLX can be Risky if you Don''t Have Discipline

Stock Traders Daily Stock Traders Daily, 23 days ago
Breast Cancer Diagnostics Global Market Report 2023

Breast Cancer Diagnostics Global Market Report 2023

Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V, Fujifilm Holdings C...

GlobeNewswire GlobeNewswire, 28 days ago
Never miss a trade
To improve your user experience we use cookies.